T he main function of arterial endothelial cells (ECs) is to facilitate blood flow in the high-pressure, high-velocity arterial circulation by adopting a quiescent phenotype, characterized by a low proliferation rate and permeability. High shear stress promotes the adaptation of arterial ECs, which sense hemodynamic stress and transduce this input into signaling events that regulate transcriptional modules, such as the activation of the transcription factor Krüppel-like factor 2 (KLF2). 1 Under normal physiological conditions, blood flow is disturbed at branching points of arteries, which results in inflammatory activation and endoplasmic reticulum stress in ECs, thereby promoting their death and detachment from the vessel wall. 2 However, endothelial denudation of the luminal surface rarely occurs, probably because of the immediate repair by regenerative proliferation of neighboring ECs, thus compensating the disturbed flow-induced endothelial damage. 3 Downregulation of KLF2 by disturbed flow controls the regenerative growth of ECs by the reduced expression of microRNA (miR)-126-5p, which limits the proliferative reserve of ECs on additional damage, such as that caused by hyperlipidemic stress, and increases atherosclerosis. 3 Although the role of KLF2 in ECs on atherosclerosis has not been established in vivo, suppression of KLF2 by miR-92a at predilection sites of atherosclerosis is closely linked to lesion formation. 4, 5 In addition to miR-126-5p, endothelial KLF2 mediates the shear stress-induced upregulation of various microRNAs, such as miR-23b, miR-143, and miR-145. Whereas miR-143 and miR-145 are transferred from ECs to smooth muscle cells via microvesicles, miR-23b limits endothelial proliferation under high shear stress conditions by decreasing E2F transcription factor 1 expression and hypophosphorylation of the retinoblastoma-associated protein 1 (Rb1). 6, 7 Therefore, KLF2 may balance endothelial regeneration by regulating microRNAs with opposing effects on EC proliferation.
See accompanying article on page 1437 in the July 2014 issue
In the July issue of Arteriosclerosis, Thrombosis, and Vascular Biology, Wang et al 8 confirm that upregulation of KLF2 by pulsatile shear stress triggers miR-23b expression in ECs. Furthermore, the authors now unveiled the mechanism by which miR-23b limits EC proliferation under high shear stress conditions (Figure) . They found that inhibition of miR-23b increased the expression and phosphorylation of Cyclin-dependent kinase (CDK) 2 and CDK4. The activation of CDK2/4 is mainly mediated by the trimeric, constitutively active CDK-activating kinase (CAK) protein complex comprising Cyclin H, CDK7, and the RING finger protein ménage-à-trois 1 that coordinates the sequential activation of CDK2 and CDK4 during cell cycle progression. 9, 10 In addition to its role in cell cycle progression, the CAK complex is a component of the transcription factor TFIIH (transcription factor II human) and regulates gene expression by phosphorylation of serines (Ser) 5 and 7 of the carboxy-terminal domain of RNA polymerase II. Wang et al 8 In this model of acutely disturbed blood flow, intimal macrophage accumulation occurs early after partial ligation, which can expand locally in arteries by proliferation. 11, 12 Thus, differences in the number or proliferating luminal cells could be because of effects of miR-23b on monocytes recruitment rather than on endothelial proliferation. Notably, miR-23b can suppress the activation of nuclear factor-κB by proinflammatory cytokines and may thereby reduce the inflammatory activation of ECs and the recruitment of monocytes. 13 Therefore, it would be important to specifically test the effect of miR-23b on the proliferation of arterial ECs in vivo. Furthermore, the role of miR-23b in the adoption of a low replicative EC phenotype in arterial regions with undisturbed flow is unclear.
In this regard, it may be interesting to test whether inhibition of miR-23b enhances EC proliferation in these arterial segments.
To assess the clinical implications of the findings from Wang et al, 8 additional work is required. However, the current report adds significantly to the understanding of the mechanisms directing endothelial proliferation in arteries, which is required to develop therapeutic strategies to improve endothelial health in vascular diseases, such as atherosclerosis. 
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Figure.
Molecular mechanism involved in high shear stress-induced endothelial cell growth arrest by microRNA-23b (miR-23b). Pulsatile shear flow (PS) induces the Krüppel-like factor 2 (KLF2)-dependent upregulation of miR-23b, which targets Cyclin H mRNA into the RISC complex. Reduction of Cyclin H leads to a reduction of Cdk-activating kinase (CAK) complex activity and thereby decreases Ser5 phosphorylation to the C-terminal domain (CTD) of polymerase II (Pol II) and CDK2/4 activation. The downregulation of CDK2/4 by miR-23b is attributable to the reduced Ser5 phosphorylation of Pol II. The inactivation of CDK2/4 by miR-23b results in increase the hypophosphorylation of retinoblastomaassociated protein (Rb) and cell cycle arrest. OS indicates oscillatory shear stress; and RISC, RNAinduced silencing complex.
